Why Is Pulmonary Arterial Hypertension Often Misdiagnosed?
At a Glance
Pulmonary arterial hypertension is often diagnosed late because early shortness of breath and fatigue resemble common conditions, while routine tests may be normal or inconclusive. Diagnosis requires ruling out other causes and confirming high pressures with right heart catheterization.
Finding out you have pulmonary arterial hypertension (PAH) often comes after a long, frustrating journey of medical appointments and changing diagnoses. If you are wondering why it took so long for your doctors to figure out you have PAH, you are not alone. The primary reason for this delay is that the early symptoms of PAH—such as shortness of breath and fatigue—are non-specific and can resemble the symptoms of much more common conditions [1] [2]. Because PAH is a rare disease, doctors may initially suspect and test for common illnesses first [3]. Studies of different patient groups have reported average diagnostic delays ranging from over a year to three years, often requiring visits to multiple clinicians before reaching a final answer [4] [5] [6].
The Challenge of Early Symptoms
In its early stages, PAH does not have unique, unmistakable signs. The most common presenting symptoms are shortness of breath during physical activity (dyspnea) and unusual fatigue [1] [2] [7]. Because these symptoms are so common, they may be attributed to other causes:
- Asthma or respiratory infections: Doctors might prescribe inhalers or antibiotics, exploring common lung issues [8].
- Anxiety or stress: When routine tests come back normal, breathlessness may be considered a symptom of anxiety [7].
- Deconditioning or aging: Fatigue and getting winded on stairs are sometimes attributed to being out of shape or getting older [2].
These common conditions can also coexist with PAH, making it even harder to recognize when they do not fully explain your symptoms. Some patients report their experiences of these symptoms are dismissed when routine tests look normal.
When to Seek Immediate Help: If you experience severe or rapidly worsening breathlessness, breathlessness at rest, significant chest pain, or if you faint (syncope), seek emergency medical care immediately [9] [10]. Do not wait for a routine specialist appointment.
The Diagnostic Hurdle
Diagnosing PAH is a complex process. Pulmonary hypertension (PH) is an umbrella term for high blood pressure in the lungs, and PAH is just one specific type (known as Group 1). Confirming PAH requires proving that the high pressure exists and ruling out all other possible causes.
- Routine tests are often normal: Initial evaluations like electrocardiograms (ECGs) and chest X-rays might look completely normal or show only subtle changes [11].
- Echocardiogram limitations: An ultrasound of the heart (echocardiogram) is a key noninvasive test used to estimate the likelihood of pulmonary hypertension [1]. However, it cannot directly measure pressures and its estimates can be inaccurate [12] [13]. It cannot definitively diagnose PAH, and a normal echocardiogram does not completely rule out PAH if symptoms continue.
- Ruling out other causes: Before confirming PAH, doctors must look for other reasons for high lung pressure. This usually involves pulmonary function tests to check for lung disease and a ventilation/perfusion (V/Q) scan to rule out chronic blood clots in the lungs [14] [11] [15].
- The need for right heart catheterization: To confirm pulmonary hypertension, a doctor must perform a right heart catheterization [14]. This procedure directly measures right-sided heart pressures, pulmonary artery pressures, and pulmonary artery wedge pressure [16]. These specific measurements help prove the diagnosis and ensure the high pressures are not caused by left-heart disease [17] [18].
Navigating the Healthcare System
Even when doctors suspect pulmonary hypertension, getting the final diagnosis can be delayed by systemic barriers. Evaluation and treatment planning should ideally involve a specialized pulmonary hypertension center [14] [10]. However, referrals to these centers are often delayed [19].
Patients may wait months to see specialists or face barriers related to travel distance, insurance, and socioeconomic factors [20]. Studies show that living farther away from a specialty center or facing mental health and socioeconomic challenges can significantly extend the time it takes to get an accurate diagnosis [20] [6]. Shared or coordinated care between your local doctor and a specialist center can help when travel or access is a barrier.
Understanding this diagnostic delay can help validate your experience. Now that you have an accurate diagnosis, you and your care team can focus on the right treatments and disease management.
Common questions in this guide
Why is pulmonary arterial hypertension often mistaken for something else?
How long does it usually take to receive a PAH diagnosis?
Can normal test results or an echocardiogram rule out PAH?
What test confirms pulmonary arterial hypertension?
When should I seek emergency care for possible PAH?
How can a pulmonary hypertension center help when diagnosis or care is delayed?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About early symptoms
Could my breathlessness and tiredness have other causes first?
About testing
Should I have an echocardiogram now, and what would it tell us?
Specialist referrals
Should I be referred to a pulmonary hypertension center?
Related questions
Show more
Get notified when new evidence is published on Idiopathic/heritable pulmonary arterial hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Pulmonary Arterial Hypertension: Recognition and Management in Primary and Acute Care Settings.
Ahern BJ, Fulford ST, Long D, Miller CL
Cureus 2025; (17(12)):e100073 doi:10.7759/cureus.100073.
PMID: 41583269 - 2
Presenting symptom patterns of pulmonary arterial hypertension across adult age groups and etiologies: Implications for early recognition.
Hoch CR, Brewer B, Matura LA
Heart & lung : the journal of critical care 2026; (78()):102837 doi:10.1016/j.hrtlng.2026.102837.
PMID: 42155938 - 3
Screening strategies for pulmonary arterial hypertension.
Kiely DG, Lawrie A, Humbert M
European heart journal supplements : journal of the European Society of Cardiology 2019; (21(Suppl K)):K9-K20 doi:10.1093/eurheartj/suz204.
PMID: 31857796 - 4
The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
Small M, Perchenet L, Bennett A, Linder J
Therapeutic advances in respiratory disease 2024; (18()):17534666231218886 doi:10.1177/17534666231218886.
PMID: 38357903 - 5
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.
Khou V, Anderson JJ, Strange G, et al.
Respirology (Carlton, Vic.) 2020; (25(8)):863-871 doi:10.1111/resp.13768.
PMID: 31997504 - 6
Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension Patients in Gansu China: A Observational Cohort Study.
Zhang J, Meng H, Yin Y, et al.
Current problems in cardiology 2023; (48(12)):102026 doi:10.1016/j.cpcardiol.2023.102026.
PMID: 37553061 - 7
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
Ruopp NF, Cockrill BA
JAMA 2022; (327(14)):1379-1391 doi:10.1001/jama.2022.4402.
PMID: 35412560 - 8
Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial Hypertension.
DuBrock HM, Silvert E, Doddahonnaiah D, et al.
Pulmonary circulation 2025; (15(4)):e70208 doi:10.1002/pul2.70208.
PMID: 41409317 - 9
Diagnostic Delays and Quality of Life in Japanese Patients with Pulmonary Hypertension: A Nationwide Survey.
Murakami N, Asano D, Tokushige N, et al.
Pulmonary therapy 2025; (11(2)):249-268 doi:10.1007/s41030-025-00290-6.
PMID: 40100574 - 10
Recent Advances in the Diagnosis and Management of Pulmonary Arterial Hypertension.
Mullen E, McCullagh B, Gaine S, Quadery SR
British journal of hospital medicine (London, England : 2005) 2025; (86(2)):1-13 doi:10.12968/hmed.2024.0635.
PMID: 39998132 - 11
Pulmonary Hypertension: A Brief Guide for Clinicians.
Mandras SA, Mehta HS, Vaidya A
Mayo Clinic proceedings 2020; (95(9)):1978-1988 doi:10.1016/j.mayocp.2020.04.039.
PMID: 32861339 - 12
Diagnostic and prognostic value of echocardiography in pulmonary hypertension: an umbrella review of systematic reviews and meta-analyses.
Dong TX, Zhu Q, Wang ST, et al.
BMC pulmonary medicine 2023; (23(1)):253 doi:10.1186/s12890-023-02552-y.
PMID: 37430308 - 13
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography.
Augustine DX, Coates-Bradshaw LD, Willis J, et al.
Echo research and practice 2018; (5(3)):G11-G24.
PMID: 30012832 - 14
Definition, classification and diagnosis of pulmonary hypertension.
Kovacs G, Bartolome S, Denton CP, et al.
The European respiratory journal 2024; (64(4)) doi:10.1183/13993003.01324-2024.
PMID: 39209475 - 15
Chronic thromboembolic pulmonary hypertension.
Kim NH, Delcroix M, Jais X, et al.
The European respiratory journal 2019; (53(1)) doi:10.1183/13993003.01915-2018.
PMID: 30545969 - 16
Right heart catheterisation: best practice and pitfalls in pulmonary hypertension.
Rosenkranz S, Preston IR
European respiratory review : an official journal of the European Respiratory Society 2015; (24(138)):642-52 doi:10.1183/16000617.0062-2015.
PMID: 26621978 - 17
Clinical Characteristics of Patients Undergoing Right Heart Catheterizations in Community Hospitals.
Jansen SMA, Huis In 't Veld AE, Tolen PHCG, et al.
Journal of the American Heart Association 2022; (11(17)):e025143 doi:10.1161/JAHA.121.025143.
PMID: 36062610 - 18
State of the Art in Pulmonary Arterial Hypertension: Molecular Basis, Imaging Modalities, and Right Heart Failure Treatment.
Shafeghat M, Raza Y, Catania R, et al.
Biomedicines 2025; (13(7)) doi:10.3390/biomedicines13071773.
PMID: 40722843 - 19
New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
Hill NS, Cawley MJ, Heggen-Peay CL
Journal of managed care & specialty pharmacy 2016; (22(3 Suppl A)):S3-21 doi:10.18553/jmcp.2016.22.3-a.s3.
PMID: 27003666 - 20
Factors Associated with Referral to Expert Providers among Patients with Pulmonary Hypertension.
Gillmeyer KR, Rinne ST, Rucci JM, et al.
Annals of the American Thoracic Society 2025; (22(6)):838-845 doi:10.1513/AnnalsATS.202408-901OC.
PMID: 39932507
This page explains why PAH can be difficult to recognize and confirm for informational purposes only and does not constitute medical advice. Ask your healthcare team to interpret your test results and evaluate worsening breathlessness, chest pain, or fainting.